272 A multicenter prospective phase II study of oxaliplatin (OXA), 5-fluorouracil 95FU) and leucovorin (LV) followed, by irininotecan (IRI), 5FU and LV after progression, in patients (pts) with untreated metastatic colorectal carcinoma (MCRC)

✍ Scribed by C. Almanza; L. De Paz; M. Valladares; M. Jorge; S. Candamio; M. Salgado; C. Castañon; E. Alvarez; C. Romero; F. Vazquez

• Book ID: 118620447
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 172 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90305-3